FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

423911000001107: Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2212381000001117 Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2212391000001115 Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
16041701000001118 Tenormin LS 50mg tablets (AstraZeneca) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16041801000001110 Tenormin LS 50mg tablets (AstraZeneca) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54083401000001116 Tenormin LS 50mg tablets (AstraZeneca UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Is a Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has active ingredient Atenolol false Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Is a Tenormin true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has specific active ingredient Atenolol true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) 28 tablet 2 x 14 tablets Is pack of False Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Inferred relationship Existential restriction modifier
Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Tenormin LS 50mg tablets (Atnahs Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start